The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.00
Bid: 32.50
Ask: 33.50
Change: 0.50 (1.54%)
Spread: 1.00 (3.077%)
Open: 32.50
High: 33.00
Low: 32.50
Prev. Close: 32.50
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Follow-On Investment into Existing Royalty Partner

18 Mar 2022 07:00

RNS Number : 2090F
Duke Royalty Limited
18 March 2022
 

18 March 2022

 Duke Royalty Limited

 

("Duke Royalty", "Duke" or the "Company")

 

Follow-On Investment into Existing Royalty Partner

 

 

Duke Royalty Limited (AIM: DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and North America, is pleased to announce a follow-on investment of CA$10.3 million (approximately £6.2 million) into its existing royalty partner Creō-Tech Industrial Group Inc. ("Creō-Tech").

 

Creō-Tech is a Canadian holding company that acquires businesses within the engineering, procurement and construction ("EPC") sector in both commercial and industrial settings.

 

Highlights:

 

· Creō-Tech will use this contribution from Duke to acquire California based MD Stainless Services, which specialises in the design, engineering, fabrication and installation of sanitary processing systems for the pharmaceutical, biotech, diary, food and beverage industries

· The financing increases Duke's total investment into Creō-Tech to CA$18.5 million (approximately £10.9 million)

· MD Stainless Services represents Creō-Tech's first acquisition supported by Duke, in line with Creō-Tech's stated buy-and-build strategy

· All other terms of the follow-on contribution are the same as Duke's previous investment into Creō-Tech 

 

Neil Johnson, CEO of Duke Royalty, said:

 

"This deal is consistent with our current investment strategy, in that it supports a strong management team that is executing a buy-and-build model through the acquisition of long standing, profitable companies in attractive niche and high margin markets.

 

"With our investment into Creō-Tech last year we successfully entered into North American markets, and this transaction represents a transformative and important acquisition for Creō-Tech. Along with our other North America royalty partner, Atlas Holdings, Creō-Tech demonstrates the global appeal of Duke's capital and the quality of opportunities in that market."

 

Dirk Maritz, CEO of Creō-Tech, said:

 

"We are incredibly fortunate to partner with Duke Royalty for this venture. Their capital enables business owners to grow their businesses without compromising control or ownership and removes refinancing risk. With this partnership, Creō-Tech continues to pursue further targeted acquisitions that will fuel continued strategic growth.

 

"This acquisition continues the successful execution on our buy and build strategy. We now offer the North American market a full-service solution in very specific niche markets that includes industrial engineering, design, manufacturing, construction and automation."

 

About MD Stainless Services

 

Founded in 1988, MD Stainless Services is a long-standing, profitable, and owner-managed business that specialises in the design, engineering, fabrication and installation of sanitary processing systems for the pharmaceutical, biotech, diary, food and beverage industries.

 

Engineering & installation includes:

· complete stainless steel process plants & utility piping

· water & liquid injection systems

· de-ionized water systems

· ozone systems

· domestic water hook-ups

· treated water systems & chilled piping systems

· cooling towers

· utility stations

· flow panels

· enclosures

· electro-mechanical systems

 

With Creō-Tech's engineering capability, project management expertise and support, MD Stainless Services is expected to continue growing in existing markets and gaining a larger share of the food and beverage, pharmaceutical, nutraceuticals and semi-conductor industries.

 

About Creō-Tech

 

Creō-Tech is a privately-owned group of companies offering innovative multi-disciplinary engineering and manufacturing applications in energy, power generation, material handling, mining, manufacturing and processing, food & beverage, pharmaceuticals, telecommunications and utilities markets. In addition to its reputable manufacturing, fabrication and electro-mechanical construction operations, Creō-Tech offers a full complement of services to the North American Industrial mid-market, including structural, electrical, mechanical & electro-mechanical design and engineering services, solutions driven automation and various technical support solutions. Creō-Tech offers a competitive advantage by executing on a customized approach, to meet client's needs with innovative solutions. To learn more, visit Creōtechgroup.com.

 

 

***ENDS***

 

For further information, please visit www.dukeroyalty.com or contact:

 

Duke Royalty Limited

Neil Johnson / Charles Cannon Brookes / Hugo Evans

 

+44 (0) 1481 730 613

Cenkos Securities plc 

(Nominated Adviser

and Joint Broker)

Stephen Keys / Callum Davidson / Julian Morse / Michael Johnson

+44 (0) 207 397 8900

 

 

 

Canaccord Genuity

(Joint Broker)

 

Adam James / Georgina McCooke

+44 (0) 207 523 8000

SEC Newgate (PR)

Elisabeth Cowell/ Richard Bicknell/ Max Richardson

+44 (0) 20 3757 6880 dukeroyalty@secnewgate.co.uk

 

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCJRMMTMTBBTLT
Date   Source Headline
3rd May 20247:00 amRNSFollow-On Investment into Existing Capital Partner
29th Apr 20242:45 pmEQSHardman & Co Research Initiation of Coverage on Duke Capital (DUKE): Meeting customer needs, giving investors returns
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat
6th Mar 20247:00 amRNSSuccessful Exit of Investment
4th Mar 20247:00 amRNSIncreased Equity Stake in United Glass Group
21st Feb 202411:57 amRNSName Change Effective
20th Feb 202412:08 pmRNSResult of General Meeting & Change of Name
5th Feb 20247:00 amRNSProposed Change of Name, Website and Messaging
29th Dec 20237:00 amRNSTrading Update and Follow-on Investment
19th Dec 20237:00 amRNSInterim Dividend and Dividend Declaration
29th Nov 20237:00 amRNSUpdate re. Change of Name of Nominated Adviser
22nd Nov 20237:00 amRNSFinancial Year 2024 Interim Results
21st Sep 20237:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20237:00 amRNSTrading Update
2nd Aug 20234:51 pmRNSResult of Annual General Meeting
31st Jul 20237:00 amRNSNew Royalty Agreement
28th Jul 20237:00 amRNSDirector/PDMR Dealings
20th Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
4th Jul 20237:00 amRNSFinal Results for the year ended 31 March 2023
3rd Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
26th Jun 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
15th Jun 20237:00 amRNSInterim Dividend and Dividend Declaration
9th Jun 20237:00 amRNSNotice of Results
1st Jun 20237:00 amRNSTrading Update
25th May 20237:00 amRNSDirectors' Dealings
24th May 20237:00 amRNSSuccessful Exit of Investment in Royalty Partner
22nd Mar 20237:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20237:00 amRNSNew Royalty Agreement
3rd Mar 20237:00 amRNSTrading Update
21st Feb 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
16th Jan 20237:00 amRNSClosing of New Credit Facility
15th Dec 20223:35 pmRNSInterim Dividend and Dividend Declaration
13th Dec 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
12th Dec 20227:00 amRNSRefinance and Upsize of Credit Facility
1st Dec 20227:01 amRNSTrading Update
1st Dec 20227:00 amRNS2023 Interim Results
29th Nov 202212:38 pmRNSResult of Annual General Meeting
25th Nov 20227:00 amRNSNew Royalty Agreement
14th Nov 20227:00 amRNSNotice of AGM and Notice of Interim Results
14th Oct 20227:00 amRNSPSAs, Issue of Equity & Director/PDMR Dealings
22nd Sep 20227:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20229:09 amRNSPublication of Annual Report & Accounts
9th Sep 20227:00 amRNSPostponement of Presentation
8th Sep 20227:00 amRNSFinal Results for the year ended 31 March 2022
31st Aug 20225:04 pmRNSHolding(s) in Company
30th Aug 20223:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.